Dopavision
0 followers
The goal of the Berlin-based startup is to develop a clinically validated therapy for myopia progression in children and adolescents. The technology delivers light stimulation to specific photosensitive cells on the retina which in turn modulate dopamine, a neurotransmitter that is important for the... Read more
Org chart
Mark Wuttke
Chief Executive Officer
Mark Wuttke
Collapse
Andreas Balser
Chief Technology Officer
Imane Wild
Chief Medical Officer
Stefan Zundel
Co-Founder and Managing Director
Hamed Bahmani
Founder and Managing Director
Gabriela Burian
Consulting Chief Medical Officer
Georgios Parafentis
Product Manager
Vicky Gravia
Strategy and Operations Manager
Yeshwanth Seshadri
Product Manager
Jens Ellrich, MD, PhD
Chief Scientific Officer And Medical Consultant
